InvestorsHub Logo
Followers 42
Posts 4161
Boards Moderated 0
Alias Born 01/04/2017

Re: marzan post# 242556

Thursday, 09/05/2019 7:11:05 AM

Thursday, September 05, 2019 7:11:05 AM

Post# of 711210
I am actually up near Cullman, but a cup of coffee and a good NWBO discussion could happen tomorrow if you want....:)

From the PR:
In his roles at Merck, Dr. Duffy has been involved in the Keytruda development program from its early days through its wide commercialization. He has gained extensive experience with clinical trial designs and strategies, clinical results and feedback from medical professionals.

Sounds to me like he is going to help NWBO get fda approval and that approval for as many indications as possible. Again, I am wondering why Merck would just let him go to a competitor.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News